Cargando…
HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer
Gastric cancer is a serious health problem worldwide. Although its incidence is decreasing, the five-year survival rate remains low. Thus, it is essential to identify new biomarkers that could promote better diagnosis and treatment of patients with gastric cancer. High-mobility group AT-hook 1 (HMGA...
Autores principales: | Pádua, Diana, Pinto, Débora Filipa, Figueira, Paula, Pereira, Carlos Filipe, Almeida, Raquel, Mesquita, Patrícia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774981/ https://www.ncbi.nlm.nih.gov/pubmed/35049679 http://dx.doi.org/10.3390/curroncol29010005 |
Ejemplares similares
-
High-Throughput Drug Screening Revealed That Ciclopirox Olamine Can Engender Gastric Cancer Stem-like Cells
por: Pádua, Diana, et al.
Publicado: (2023) -
The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication
por: Pádua, Diana, et al.
Publicado: (2020) -
A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin
por: Pádua, Diana, et al.
Publicado: (2020) -
Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
por: Ribeirinho-Soares, Sara, et al.
Publicado: (2021) -
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer
por: Maurizio, Elisa, et al.
Publicado: (2016)